yingweiwo
  1. Home
  2. Products
  3. Signaling Pathways
  4. Neuronal Signaling
  5. Beta Amyloid

Beta Amyloid

Beta Amyloid

Beta Amyloid related products

Structure Cat No. Product Name CAS No. Product Description
4-Sulfocalix[4]arene V111853 4-Sulfocalix[4]arene 112269-92-8 4-Sulfocalix[4]arene (p-sulfonocalix[n]arene) is an amyloid β42 (amyloid β42) binder with a Kd value of 5.39 M.
AAKLVFF V113880 AAKLVFF 1038400-67-7 AAKLVFF is an oligopeptide that can self-assemble into nanotubes.
AChE-IN-59 V87778 AChE-IN-59 2957916-86-6 AChE-IN-59 (compounds 3b) is an inhibitor of AChE with an IC50 value of 0.05 µM.
AChE/BChE-IN-12 V79262 AChE/BChE-IN-12 AChE/BChE-IN-12 (compound 10b), a 3,5-dimethoxy analog, is a potent inhibitor of AChE, BChE and beta-secretase-1 (BACE-1) with IC50s respectively are 2.57, 3.26 and 10.65 μM.
Amyloid β-Protein (3-42) TFA V128798 Amyloid β-Protein (3-42) TFA Amyloid β-Protein (3-42) TFA is a precursor of Pyr peptide.
Amyloid-β-IN-1 V128799 Amyloid-β-IN-1 Amyloid-β-IN-1 is a synthetic peptide containing the hydrophobic C-terminal region “VVIA-NH2” of Aβ42 and its reverse sequence “AIVV-NH2”, and is an Aβ inhibitor.
Aβ aggregation-IN-4 V111796 Aβ aggregation-IN-4 603113-07-1 The Aβ aggregation inhibitor IN-4 can alleviate the neurotoxicity of β-amyloid (Aβ) and significantly reduce the level of Aβ oligomer complexes (Aβ-OCs).
Aβ-IN-6 V78525 Aβ-IN-6 Aβ-IN-6 reduces proinflammatory cytokine release from microglia.
Cbz-Gly-Pro-Ala-O-cinnamyl V88215 Cbz-Gly-Pro-Ala-O-cinnamyl Cbz-Gly-Pro-Ala-O-cinnamyl (compound 25) is a small peptide targeting BACE-1 and AChE with IC50 values of 0.02 μM and 1 μM, respectively.
Coumarinic acid V71432 Coumarinic acid 495-79-4 Coumarinic acid is a brain-penetrating inhibitor of AChE and β-amyloid.
Donanemab (Mouse IgG2a) V134181 Donanemab (Mouse IgG2a) Donanemab (Mouse IgG2a) is a mouse-derived IgG2 monoclonal antibody used in research on Alzheimer's disease.
Emrusolmin (Anle138b) V11347 Emrusolmin (Anle138b) 882697-00-9 Anle138b is a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.
Glutaminyl Cyclase Inhibitor 6 V87776 Glutaminyl Cyclase Inhibitor 6 Glutaminyl Cyclase Inhibitor 6 (compound BI-43) is a secretory glutaminyl cyclase (sQC) and golgi-resident glutaminyl cyclase (gQC) inhibitor with IC50 values of 0.012 and 0.040 µM, respectively.
Glycerophosphorylethanolamine sodium V136771 Glycerophosphorylethanolamine sodium 883288-78-6 Glycerophosphorylethanolamine sodium is an active phosphodiester metabolite of phosphatidylethanolamine.
hAChE/hBACE-1-IN-2 V79406 hAChE/hBACE-1-IN-2 hAChE/hBACE-1-IN-2 is a potent, orally bioactive, BBB (blood-brain barrier) permeable (penetrable) triple inhibitor of hAChE/hBChE/hBACE-1 with IC50s of 0.113 μM, 1.48 μM and 0.38 μM respectively.
LPYFD-NH2 TFA V80619 LPYFD-NH2 TFA LPYFD-NH2 TFA is a pentapeptide that can inhibit the aggregation of Aβ(1-42).
Methyl tridecanoate V71441 Methyl tridecanoate 1731-88-0 Methyl tridecanoate moderately inhibits β-amyloid protein (β-amyloid) aggregation.
MG-H1 V109021 MG-H1 149204-50-2 MG-H1 is a ligand for the receptor for advanced glycation end products (RAGE) with a dissociation constant (Kd) of 4.12 nM.
Mivelsiran sodium scrambled negative control V140013 Mivelsiran sodium scrambled negative control The Mivelsiran sodium scrambled negative control is a negative control for Mivelsiran sodium with a scrambled sequence.
N-Caffeoyldopamine V141055 N-Caffeoyldopamine N-Caffeoyldopamine is a β-amyloid aggregation inhibitor.
Contact Us
Tel: 1-708-310-1919 Fax: 1-708-557-7486 Email: [email protected] Frequently Asked Questions
Subscribe to our E-newsletter
Name
E-mail

Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved

linkedin facebook
Contact Us
Home Product Cart Member